Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Retained Earnings: 2021-2024

Historic Retained Earnings for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to -$687.2 million.

  • Prime Medicine's Retained Earnings fell 30.60% to -$842.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$842.3 million, marking a year-over-year decrease of 30.60%. This contributed to the annual value of -$687.2 million for FY2024, which is 39.87% down from last year.
  • Prime Medicine's Retained Earnings amounted to -$687.2 million in FY2024, which was down 39.87% from -$491.3 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Retained Earnings ranged from a high of -$171.4 million in FY2021 and a low of -$687.2 million during FY2024.
  • For the 3-year period, Prime Medicine's Retained Earnings averaged around -$490.6 million, with its median value being -$491.3 million (2023).
  • Data for Prime Medicine's Retained Earnings shows a maximum YoY slumped of 71.08% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Prime Medicine's Retained Earnings stood at -$171.4 million in 2021, then tumbled by 71.08% to -$293.2 million in 2022, then slumped by 67.58% to -$491.3 million in 2023, then crashed by 39.87% to -$687.2 million in 2024.